Page last updated: 2024-10-24

chloroquine and Severe Combined Immunodeficiency

chloroquine has been researched along with Severe Combined Immunodeficiency in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Severe Combined Immunodeficiency: Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pathak, SS1
Blum, JS1

Other Studies

1 other study available for chloroquine and Severe Combined Immunodeficiency

ArticleYear
Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.
    Traffic (Copenhagen, Denmark), 2000, Volume: 1, Issue:7

    Topics: Anti-Bacterial Agents; Antigen Presentation; Antigens, Viral; Biotinylation; Brefeldin A; Cell Line;

2000